1997
DOI: 10.1021/tx970048z
|View full text |Cite
|
Sign up to set email alerts
|

Both Cytochromes P450 2E1 and 3A Are Involved in the O-Hydroxylation of p-Nitrophenol, a Catalytic Activity Known To Be Specific for P450 2E1

Abstract: 4-Nitrophenol 2-hydroxylation activity was previously shown to be mainly catalyzed by P450 2E1 in animal species and humans. As this chemical compound is widely used as an in vitro probe for P450 2E1, this study was carried out to test its catalytic specificity. First, experiments were carried out on liver microsomes and hepatocyte cultures of rat treated with different inducers. Liver microsomes from pyrazole- and dexamethasone-treated rats hydroxylated p-nitrophenol with a metabolic rate increased by 2.5- an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

1998
1998
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(24 citation statements)
references
References 35 publications
0
24
0
Order By: Relevance
“…Measurement of chlorzoxazone and trimethadione metabolism by CYP2E1 has also been used as an indicator for liver diseases in vivo and in vitro (Dilger et al, 1997;Burckart et al, 1998;Mishin et al, 1998;Dupont et al, 2000). An alternative method for measuring CYP2E1 activity has been to analyze p-nitrophenol hydroxylation ( p-nitrocatechol formation) (Zerilli et al, 1997). In this study, complete inhibition of chlorzoxazone 6-hydroxylation was not achieved due to the contribution of other P450s such as CYP1A2 to the metabolism of chlorzoxazone (Carriere et al, 1993;Ono et al, 1995).…”
Section: Discussionmentioning
confidence: 90%
“…Measurement of chlorzoxazone and trimethadione metabolism by CYP2E1 has also been used as an indicator for liver diseases in vivo and in vitro (Dilger et al, 1997;Burckart et al, 1998;Mishin et al, 1998;Dupont et al, 2000). An alternative method for measuring CYP2E1 activity has been to analyze p-nitrophenol hydroxylation ( p-nitrocatechol formation) (Zerilli et al, 1997). In this study, complete inhibition of chlorzoxazone 6-hydroxylation was not achieved due to the contribution of other P450s such as CYP1A2 to the metabolism of chlorzoxazone (Carriere et al, 1993;Ono et al, 1995).…”
Section: Discussionmentioning
confidence: 90%
“…In estradiol-treated hepatocytes, similar increases in the P450 enzyme activity were observed for multiple probe substrates of CYP2C9 (diclofenac and tolbutamide) and CYP2E1 (p-nitrophenol and chlorzoxazone). Furthermore, cotreatment of hepatocytes with a phase II enzyme inhibitor (i.e., 2 mM salicylamide) to block the known glucuronidation of p-nitrophenol (Zerilli et al, 1997;Hanioka et al, 2001) did not abolish the increased p-nitrophenol hydroxylation upon estradiol treatment (data not shown). These results suggest that potential nonspecificity of the substrates unlikely contributes to the enhanced CYP2C9 and CYP2E1 activity by estradiol.…”
Section: Discussionmentioning
confidence: 95%
“…In line with this fact, there is in the minipig probably a contribution also from the CYP3A (Madden et al, 1998) as well as the CYP1A enzymes to the metabolism of chlorzoxazone (Bogaards et al, 2000) in the microsomal preparations. The second substrate, p-nitrophenol, is known to be metabolized by CYP2E1 as well as (with lower turnover number) by CYP3A enzymes in humans (Zerilli et al, 1997). Most recent results indicate an involvement of CYP2A6 and possibly also of CYP2C19 enzymes in this reaction (Monostory et al, 2004).…”
Section: Discussionmentioning
confidence: 99%